Log in
Enquire now
BEVESPI AEROSPHERE

BEVESPI AEROSPHERE

(glycopyrrolate and formoterol fumarate) Inhalation aerosol

OverviewStructured DataIssuesContributors

Contents

bevespi.com
Is a
Product
Product

Product attributes

Industry
Pharmaceutical and Medicine Manufacturing
Pharmaceutical and Medicine Manufacturing
Product Parent Company
AstraZeneca
AstraZeneca

BEVESPI AEROSPHERE aims to open airways to the max. BEVESPI AEROSPHERE contains two medicines that work in different ways. When used long-term twice daily, BEVESPI AEROSPHERE helps to open airways and keep them open and can make it easier to breathe.

In two 24-week clinical trials, effects of BEVESPI AEROSPHERE on lung function for better breathing were shown to be greater than either of its individual medicines alone.* Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough.

*Individual results may vary

BEVESPI AEROSPHERE is not a rescue inhaler and is not for use to treat sudden COPD symptoms. It is not for use in asthma.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like BEVESPI AEROSPHERE

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.